Capellon Pharms Llc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CAPELLON PHARMS LLC, and what generic and branded alternatives to CAPELLON PHARMS LLC drugs are available?
CAPELLON PHARMS LLC has one approved drug.
Summary for Capellon Pharms Llc
| US Patents: | 0 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Capellon Pharms Llc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capellon Pharms Llc | POLMON | dexchlorpheniramine maleate | SYRUP;ORAL | 202520-001 | Jul 16, 2018 | RX | No | Yes | ⤷ Subscribe | ⤷ Subscribe | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
